Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nitric oxide

EU orphan designation number: EU/3/15/1484   
Active ingredient: Nitric oxide
Indication: Treatment of cystic fibrosis
Sponsor: Biological Consulting Europe Ltd
Wallace Building, Roslin BioCentre, Roslin, Midlothian, EH25 9PP, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/319/14 (2015)2948 of 24/04/2015